From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights.

scientific article published on January 2013

From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2174/13816128130303
P698PubMed publication ID23394093

P50authorGianluca Svegliati-BaroniQ72323940
P2093author name stringSamuele De Minicis
Chris Day
P433issue29
P921main subjectpathogenesisQ372016
hepatocellular carcinomaQ1148337
P304page(s)5239-5249
P577publication date2013-01-01
P1433published inCurrent Pharmaceutical DesignQ5195068
P1476titleFrom NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights
P478volume19

Reverse relations

cites work (P2860)
Q34070770A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease
Q60302074Bioinformatics analysis of key differentially expressed genes in non-alcoholic fatty liver disease mice models
Q33568261Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis
Q40922247Comments on "NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis".
Q56343202Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
Q34309876Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs).
Q92990488Gut microbiota, fatty liver disease, and hepatocellular carcinoma
Q35172679HCC development is associated to peripheral insulin resistance in a mouse model of NASH.
Q26764911Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
Q47138651Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
Q45061974Human germline hedgehog pathway mutations predispose to fatty liver.
Q46443002Intermittent calorie restriction largely counteracts the adverse health effects of a moderate-fat diet in aging C57BL/6J mice
Q36561514LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
Q26852606MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease
Q41969545Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis
Q30277911NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice
Q47958825Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice.
Q91992943PPAR δ inhibition protects against palmitic acid-LPS induced lipidosis and injury in cultured hepatocyte L02 cell
Q41457655Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.
Q37377220miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.

Search more.